Selvita with Evestra for Drug Metabolism & Pharmacokinetics Studies

Selvita has signed an agreement with Germany-based Evestra to deliver a range of drug metabolism, pharmacokinetic and physicochemical studies.

Poland based integrated drug discovery services provider Selvita has inked a deal with Evestra, the German subsidiary of Evestra Inc, to deliver a range of drug metabolism, pharmacokinetic and physicochemical studies.

Under the agreement, the two companies will work on drug metabolism and pharmacokinetics studies, including CYP inhibition, metabolic identification and stability. The project will also involve oral bioavailability and pharmacokinetics assays, both in vitro and in vivo, accompanied by gentotoxicity testing.

Evestra’s decision to entrust Selvita with this project gives its research team a chance to show their potential and capabilities to run complex projects in yet another field of preclinical research, according to Dr Milosz Gr